What is China Isotope & Radiation Gross-Profit-to-Asset %?
Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. China Isotope & Radiation's annualizedGross Profit for the quarter that ended in Dec. 2023 was HK$4,369 Mil.
China Isotope & Radiation's average Total Assets over the quarter that ended in Dec. 2023 was HK$13,666 Mil. Therefore, China Isotope & Radiation's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 31.97%.
China Isotope & Radiation Gross-Profit-to-Asset % Historical Data
The historical data trend for China Isotope & Radiation's Gross-Profit-to-Asset % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
China Isotope & Radiation Gross-Profit-to-Asset % Chart
Competitive Comparison of China Isotope & Radiation's Gross-Profit-to-Asset %
For the Medical Devices subindustry, China Isotope & Radiation's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Isotope & Radiation's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, China Isotope & Radiation's Gross-Profit-to-Asset % distribution charts can be found below:
* The bar in red indicates where China Isotope & Radiation's Gross-Profit-to-Asset % falls into.
China Isotope & Radiation Gross-Profit-to-Asset % Calculation
China Isotope & Radiation's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Gross Profit data used here is two times the semi-annual (Dec. 2023) data.
Gross-Profit-to-Asset % is displayed in the 30-year financial page.
China Isotope & Radiation Gross-Profit-to-Asset % Related Terms
Thank you for viewing the detailed overview of China Isotope & Radiation's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.
China Isotope & Radiation (HKSE:01763) Business Description
China Isotope & Radiation Corp is a Chinese company. It has five operating segments: Pharmaceuticals; Radioactive source products; Irradiation; Radiation therapy equipment and related services and Other businesses. Its Pharmaceutical segment is the key revenue driver, which manufactures and sells imaging diagnostic and therapeutic radiopharmaceuticals imaging, UBT diagnostic kits, and test analyzers, and other products. Its radioactive source products segment involves the sale of medical and industrial radioactive source products and technical services. The Group's operations are carried out and majority of the Group's customers are located in the PRC.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01763 has been successfully added to your 